<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Release of oxygen free radicals occurs following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Studies show that oxygen free radicals mediate ischemic brain injury </plain></SENT>
<SENT sid="2" pm="."><plain>CoQ10 is a potent free radical scavenger and may offset brain injury associated with reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>We tested exogeneous CoQ10 as a neuroprotectant in rats following both global and focal ischemic insults </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Rats were subjected to either 4-vessel occlusion <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (4-VO, 10 min occlusion, 7-day survival) or middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO, 120 min-occlusion, 22.5 h survival) </plain></SENT>
<SENT sid="5" pm="."><plain>Regional cerebral blood flows (rCBF) and physiological variables such as blood pressure, pO2, pCO2, plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and hematocrit were monitored and measured in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The animals were randomized to receive treatments of either phosphate buffered saline (PBS) vehicle or CoQ10 following global or focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Injection times were at the end of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 3 h later for both models of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Histological outcomes are expressed as a percentage of hippocampal CA(1) cell injury in global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or percentage of cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> over that of non-ischemic hemisphere in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: In global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, animals treated with PBS vehicle and CoQ10 had 86+/-5% (n=8) and 83+/-10% (n=8), respectively, of hippocampal CA(1) cell injury (P&gt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>The percentage of <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes in animals following focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were 23+/-9% (control, n=10) and 25+/-9% (CoQ10, n=10) </plain></SENT>
<SENT sid="11" pm="."><plain>There were no temperature or physiological differences between the two treatment groups </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0011009'>Acute</z:hpo> treatment with CoQ10 via intraperitoneal injection does not prevent neuronal injuries following global and focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>